The Cooper Companies (COO) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $1.15
- Estimate
- $1.12
- Surprise
- +2.7%
- Revenue (period 2026-07-31)
- $1.07B
- Score at report (before → after)
- 5.2 → 5.2/10
Revenue source: xbrl.
How the report landed
The Cooper Companies (COO) beat the $1.12 estimate with diluted EPS of $1.15 — a modest 2.7% upside surprise. TrendMatrix's engine moved from Hold (5.2/10) to Sell at 5.2/10 after the report.
Coverage in the report window
- Deal Dispatch: Bending Spoons Acquires Miro For $1.35B, Kinetik Up For Sale, LIV Golf Bankruptcy — benzinga, 2026-09-11
Where TrendMatrix's rating stands now
TrendMatrix currently rates COO Sell at 5.3/10.
4 of the last 4 quarters beat the estimate; this quarter's +2.7% surprise compares with a +5.9% four-quarter average. Next scheduled report: 2026-12-10.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Thin upside margin: 6.9%
- Weak growth
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $53.70
- Price target
- $57.61
- Stop
- $50.14
- Upside to target
- +7.3%
- Reward-to-risk
- 0.7:1
The stock trades at 18.5× trailing but 11.5× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 6 — a level conventionally read as oversold; trading volume is running 2.1× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.
COO at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $10.25B
- P/E (fwd)
- 11.5
- P/E (ttm)
- 18.5
- 52-week range
- $51.01–$89.83
- Off 52-week high
- 40.2%
- RSI (14)
- 6
- Volume vs avg
- 2.07×
- Score today
- 5.3/10